In today’s podcast, Dr. Murali Subramanian – Best Medical Oncologist in Kalyan Nagar is going to discuss about “Head and Neck Cancer“

Head and neck cancer refers to a group of cancers that arise in the tissues of the head and neck region, which includes the throat, larynx, nose, sinuses, mouth, salivary glands, and the lymph nodes in the neck.

To book an appointment for Cancer Treatment in Bangalore contact us on +91-9880522891 or visit: ⁠www.drmuralisubramanian.com

Head and neck cancer

Head and Neck Cancer | Best Medical Oncologist in Kalyan Nagar | Dr. Murali Subramanian

In our final episodes for 2022, podcast host Natasha Cutmore speaks with Sheffield-based Professor and Consultant in Oral and Maxillofacial Pathology, Professor Ali Khurram. He has had an unusual and interesting career which started with studying Dentistry in Pakistan, before moving to the UK for his academic and clinical training in Pathology, culminating in a FRCPath in Oral and Maxillofacial Pathology in 2016. 

The discipline of Oral and Maxillofacial Pathology is a clinical specialty, undertaken by laboratory-based dentists, is concerned with the diagnosis and assessment of diseases of the oral and maxillofacial region (that is, relating to the jaws and face, as well as head and neck). It is a branch of histopathology and, in common with medical histopathologists, oral and maxillofacial pathologists provide reports based on interpretation of tissue biopsies of varying types and of surgical resection material.

December 2022 (Part One): Professor Ali Khurrum's Life and Career

In this episode, we chat to Ali about the past, present and future of oral and maxillofacial pathology and head and neck cancer. Find out how oral and maxillofacial pathology became a pathology specialty and about the exciting tools that will be helping pathologists diagnose and treat head and neck cancer patients in the future.

December 2022 (Part Two): The past, present and future of oral and maxillofacial pathology

In celebration of Head and Neck Cancer Awareness Month this April, Oncology Data Advisor Fellows Forum and Editorial Board Members Samuel Kareff, MD, MPH; Matthew Hadfield, DO; and Nagashree Seetharamu, MD, sat down to discuss the epidemiology of head and neck squamous cell carcinomas (HNSCC), the diagnostic and treatment process of HNSCC, including:
–Epidemiologic trends
–Geographic distribution
–Approved screening methods
–Novel treatment combinations
–Side effects and adverse events
–Survivorship
–And more!

Celebrating Head and Neck Cancer Awareness Month

Could the environment around a cancer tumour hold the key to better treatments?

In this episode, PhD students Emily Lythgoe and Ellie Bunce from the University of Cambridge discuss their research into tumour microenvironments. They explain why studying these environments in ovarian cancer (in a clinical setting) and head and neck cancer (in a pre-clinical setting) is so important for predicting how tumours might respond to treatment. They also highlight the value of integrating multiple technologies to create a more complete picture of a patient and their disease.

This insightful conversation explores how their work helps to understand the building blocks of these cancers and why such complex research could be crucial for developing new ways to treat patients in the future.

Integrated Cancer Medicine: Research in Focus

Studying the tumour microenvironment

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

The Royal College of Pathologists promotes excellence in the practice of pathology. Members work across 17 specialties in healthcare, universities & industry. Find out more at www.rcpath.org

The Cancer Research UK Cambridge Centre unites over 1,000 world-leading biologists, chemists, physicists, engineers, mathematicians, computer scientists, clinicians, nurses and allied healthcare professionals from across Cambridge, UK to tackle cancer from every angle.

Our mission is to end death and disease caused by cancer through research, treatment and education. We are detecting cancer at its earliest stage and are developing personalised treatments for every patient through facilitating new collaborations and driving the translation of new scientific discoveries into clinical applications to improve patient care. By working together across a range of different disciplines, our members are breaking down the barriers between the laboratory and the clinic, enabling patients to benefit from the latest innovations in cancer science.

New tracks tagged #Head and Neck Cancer